363 related articles for article (PubMed ID: 27514962)
21. Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.
Somily AM; Garaween GA; Abukhalid N; Absar MM; Senok AC
Acta Microbiol Immunol Hung; 2016 Mar; 63(1):69-81. PubMed ID: 27020870
[TBL] [Abstract][Full Text] [Related]
22. Carbapenem resistant Enterobacteriaceae carrying New Delhi metallo-β-lactamase gene (NDM-1) in Taiwan.
Wang SJ; Chiu SH; Lin YC; Tsai YC; Mu JJ
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):248-9. PubMed ID: 23518181
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
Zeynudin A; Pritsch M; Schubert S; Messerer M; Liegl G; Hoelscher M; Belachew T; Wieser A
BMC Infect Dis; 2018 Oct; 18(1):524. PubMed ID: 30342476
[TBL] [Abstract][Full Text] [Related]
24. Further Modification of the Modified Hodge Test for Detecting Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae.
Kim HK; Park JS; Sung H; Kim MN
Ann Lab Med; 2015 May; 35(3):298-305. PubMed ID: 25932437
[TBL] [Abstract][Full Text] [Related]
25. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey.
Karabay O; Altindis M; Koroglu M; Karatuna O; Aydemir ÖA; Erdem AF
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():6. PubMed ID: 26860360
[TBL] [Abstract][Full Text] [Related]
26. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
[TBL] [Abstract][Full Text] [Related]
27. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
29. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and characteristics of extended spectrum beta-lactamases-producing Enterobacteriaceae from foods of animal origin.
Tekiner İH; Özpınar H
Braz J Microbiol; 2016; 47(2):444-51. PubMed ID: 26991276
[TBL] [Abstract][Full Text] [Related]
31. Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae.
Yıldız SS; Kaşkatepe B; Avcıküçük H; Öztürk Ş
Acta Microbiol Immunol Hung; 2017 Mar; 64(1):9-16. PubMed ID: 28357923
[TBL] [Abstract][Full Text] [Related]
32. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
[TBL] [Abstract][Full Text] [Related]
33. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
34. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).
Castanheira M; Mendes RE; Rhomberg PR; Jones RN
Microb Drug Resist; 2008 Sep; 14(3):211-6. PubMed ID: 18707552
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples.
Chowdhury G; Pazhani GP; Sarkar A; Rajendran K; Mukhopadhyay AK; Bhattacharya MK; Ghosh A; Ramamurthy T
Emerg Infect Dis; 2016 Oct; 22(10):1754-61. PubMed ID: 27649032
[TBL] [Abstract][Full Text] [Related]
36. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
[TBL] [Abstract][Full Text] [Related]
37. Global spread of New Delhi metallo-β-lactamase 1.
Poirel L; Hombrouck-Alet C; Freneaux C; Bernabeu S; Nordmann P
Lancet Infect Dis; 2010 Dec; 10(12):832. PubMed ID: 21109172
[No Abstract] [Full Text] [Related]
38. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
[TBL] [Abstract][Full Text] [Related]
39. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
40. Dissemination of NDM metallo-β-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012.
Biedenbach D; Bouchillon S; Hackel M; Hoban D; Kazmierczak K; Hawser S; Badal R
Antimicrob Agents Chemother; 2015 Feb; 59(2):826-30. PubMed ID: 25403666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
